Narrow search
Showing 1 - 4 of 4
Cover Image
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Cook, Joseph P. - 2010
Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) in 1984. In the year Hatch-Waxman was enacted, generic utilization rates were 19 percent; in contrast, today, the generic utilization rate is...
Persistent link: https://www.econbiz.de/10012462928
Cover Image
The impact of indirect government controls on US drug prices and R&D
Santerre, Rexford E.; Vernon, John A.; Giaccotto, Carmelo - In: The Cato journal : an interdisciplinary journal of … 26 (2006) 1, pp. 143-158
Persistent link: https://www.econbiz.de/10003317951
Cover Image
European pharmaceutical price regulation, firm profitability, and R&D spending
Golec, Joseph; Vernon, John A. - 2006
Persistent link: https://www.econbiz.de/10003392874
Cover Image
Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry
Giaccotto, Carmelo - In: The journal of law & economics 48 (2005) April, pp. 195 - 214
Persistent link: https://www.econbiz.de/10002895264